Are P-Shots beneficial in ED
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have solid textbook-sourced information. Let me compile the answer.
P-Shot (Priapus Shot / Platelet-Rich Plasma) for Erectile Dysfunction
The P-Shot refers to intracavernosal injection of platelet-rich plasma (PRP), marketed as a regenerative therapy for erectile dysfunction (ED). Here is what current evidence and authoritative sources say:
What It Is
The P-Shot involves injecting concentrated autologous PRP directly into the penis. The proposed mechanism is that growth factors within platelets promote regeneration of penile nerves, endothelium, and smooth muscle — theoretically restoring erectile function at a physiological level rather than simply facilitating erection pharmacologically.
Current Evidence Status
Limited and preliminary. Both major urology and neurology references classify PRP for ED as experimental:
"The Sexual Medicine Society of North America (SMSNA) released a position statement on restorative and regenerative therapies for erectile dysfunction. Given the current lack of regulatory agency approval for any restorative (regenerative) therapies for the treatment of ED... SMSNA believes that the use of shock waves, stem cells, or platelet-rich plasma is experimental and requires research protocols in compliance with Institutional Review Board approval." — Campbell-Walsh-Wein Urology
"Before the use of alternative therapies can be advocated, further research that demonstrates their mechanisms of action and meaningful [clinical benefit] is required." — Campbell-Walsh-Wein Urology
"Novel treatments are currently investigated for erectile dysfunction but are not yet tested on neurological populations. Among these treatments, injections of platelet-rich plasma, injections of stem cells... have been explored... Only [shock-wave therapy] is backed by some scientific evidence but with heterogeneous protocols and generally limited to mild and vasculogenic ED." — Bradley and Daroff's Neurology in Clinical Practice
Regulatory and Safety Position
- No regulatory approval (FDA or equivalent) exists for PRP as a treatment for ED.
- Any clinical use outside of an IRB-approved research protocol is considered off-label and experimental.
- The SMSNA explicitly states it cannot be advocated for routine clinical practice at this time.
Comparison with Other Regenerative Therapies
| Therapy | Evidence Level | Regulatory Status |
|---|---|---|
| PDE5 inhibitors (e.g., sildenafil) | Strong RCT evidence | FDA-approved |
| Li-ESWT (shock wave) | Moderate (7 RCTs, 602 pts; IIEF-EF +6.4 vs +1.65 placebo) | Experimental |
| Platelet-rich plasma (P-Shot) | Very limited | Experimental / Not approved |
| Stem cell therapy | Very limited | Experimental / Not approved |
Bottom Line
The P-Shot is not currently recommended as a standard treatment for ED. It is classified as experimental by major urology societies, lacks FDA approval, and has insufficient high-quality randomized controlled trial data to support routine use. It may be offered in some clinics commercially, but patients should be aware of the lack of regulatory backing and evidence. Established treatments (PDE5 inhibitors, vacuum erection devices, intracavernosal injections, penile prosthesis) remain the standard of care.
— Campbell-Walsh-Wein Urology, Alternative Therapies section | Bradley and Daroff's Neurology in Clinical Practice, Other Developing Treatments
This is a shared conversation. Sign in to Orris to start your own chat.